Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Liquid Biopsy Market to reach USD 16.72 billion by the end of 2030.

Global Liquid Biopsy Market Size study & Forecast, by Product and Services (Kits & Reagents, Platforms & Instruments, Services) by Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [ctDNA], Other Biomarkers), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Other Cancers), by End-user (Hospitals & Laboratories and Government & Academic Research Centers) and Regional Analysis, 2023-2030

Product Code: HLSMD-11561806
Publish Date: 20-05-2023
Page: 200

Global Liquid Biopsy Market is valued at approximately USD 4.30 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.50% over the forecast period 2023-2030. The global liquid biopsy market refers to the market for diagnostic tests that detect cancer and other diseases by analyzing genetic material or biomarkers in bodily fluids such as blood, urine, and cerebrospinal fluid. Liquid biopsy tests are non-invasive and provide a less expensive and less risky alternative to traditional tissue biopsies, which involve the removal of tissue samples from the body. The major driving factors for the Global Liquid Biopsy Market are the increasing prevalence of cancer and the growing demand for non-invasive diagnostic tests. Moreover, rising technological advancements and increasing investment in research and development are creating lucrative growth opportunities for the market over the forecast period 2023-2030.

Companies and research institutions are investing heavily in research and development to improve the sensitivity, specificity, and accuracy of liquid biopsy tests, which is driving innovation in the field. For instance, in 2020, Guardant Health invested USD 100 million in a new research and development facility focused on liquid biopsy technology. The company has also announced plans to develop new liquid biopsy tests for use in cancer diagnosis and treatment. Similarly, Grail, a leading liquid biopsy company, has raised over USD 6 billion in funding since 2020, with a significant portion of this investment dedicated to research and development. The company has developed a multi-cancer early-detection test and is currently conducting clinical trials to validate its efficacy. However, the high cost of Liquid Biopsy stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Liquid Biopsy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the largest market for liquid biopsy, driven by the presence of several key players in the region, as well as a favorable regulatory environment for the development and commercialization of new technologies. The United States is the biggest contributor to the growth of the North American liquid biopsy market. Asia Pacific is a rapidly growing market for liquid biopsy, driven by the increasing prevalence of cancer in the region and a growing focus on personalized medicine. Countries such as China, Japan, and India are expected to be major contributors to the growth of the Asia Pacific liquid biopsy market.

Major market player included in this report are:
Guardant Health
Grail
Illumina, Inc
Freenome
Biocept, Inc
Natera, Inc.
Cardiff OncologyRainDance Technologies
Adaptive Biotechnologies
Exosome Diagnostics, Inc.

Recent Developments in the Market:
Ø In November 2021, Grail announced the launch of its large-scale clinical trial, the Circulating Cell-Free Genome Atlas (CCGA) study, which aims to validate the effectiveness of its liquid biopsy technology for the early detection of cancer.
Ø In August 2020, Guardant Health announced the launch of its liquid biopsy test, Guardant360 CDx, which can detect multiple cancer biomarkers in a single blood sample.

Global Liquid Biopsy Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product and Services, Circulating Biomarker, Cancer Type, End-user, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product and Services offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product and Services:
Kits & Reagents
Platforms & Instruments
Services
By Circulating Biomarker:
Circulating Tumor Cells
Extracellular Vesicles
Circulating Tumor DNA [ctDNA]
Other Biomarkers
By Cancer Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Other Cancers
By End-user:
Hospitals & Laboratories
Government & Academic Research Centers

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Liquid Biopsy Market, by Region, 2020-2030 (USD Billion)
1.2.2. Liquid Biopsy Market, by Product and Services, 2020-2030 (USD Billion)
1.2.3. Liquid Biopsy Market, by Circulating Biomarker, 2020-2030 (USD Billion)
1.2.4. Liquid Biopsy Market, by Cancer Type, 2020-2030 (USD Billion)
1.2.5. Liquid Biopsy Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Liquid Biopsy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Liquid Biopsy Market Dynamics
3.1. Liquid Biopsy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cancer
3.1.1.2. Growing demand for non-invasive diagnostic tests
3.1.2. Market Challenges
3.1.2.1. High Cost of Liquid Biopsy
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
3.1.3.2. Rising initiatives by key market players
Chapter 4. Global Liquid Biopsy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Liquid Biopsy Market, by Product and Services
5.1. Market Snapshot
5.2. Global Liquid Biopsy Market by Product and Services, Performance – Potential Analysis
5.3. Global Liquid Biopsy Market Estimates & Forecasts by Product and Services 2020-2030 (USD Billion)
5.4. Liquid Biopsy Market, Sub Segment Analysis
5.4.1. Kits & Reagents
5.4.2. Platforms & Instruments
5.4.3. Services
Chapter 6. Global Liquid Biopsy Market, by Circulating Biomarker
6.1. Market Snapshot
6.2. Global Liquid Biopsy Market by Circulating Biomarker, Performance – Potential Analysis
6.3. Global Liquid Biopsy Market Estimates & Forecasts by Circulating Biomarker 2020-2030 (USD Billion)
6.4. Liquid Biopsy Market, Sub Segment Analysis
6.4.1. Circulating Tumor Cells
6.4.2. Extracellular Vesicles
6.4.3. Circulating Tumor DNA [ctDNA]
6.4.4. Other Biomarkers
Chapter 7. Global Liquid Biopsy Market, by Cancer Type
7.1. Market Snapshot
7.2. Global Liquid Biopsy Market by Cancer Type, Performance – Potential Analysis
7.3. Global Liquid Biopsy Market Estimates & Forecasts by Cancer Type 2020-2030 (USD Billion)
7.4. Liquid Biopsy Market, Sub Segment Analysis
7.4.1. Lung Cancer
7.4.2. Breast Cancer
7.4.3. Colorectal Cancer
7.4.4. Prostate Cancer
7.4.5. Liver Cancer
7.4.6. Other Cancers
Chapter 8. Global Liquid Biopsy Market, by End-user
8.1. Market Snapshot
8.2. Global Liquid Biopsy Market by End-user, Performance – Potential Analysis
8.3. Global Liquid Biopsy Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
8.4. Liquid Biopsy Market, Sub Segment Analysis
8.4.1. Hospitals & Laboratories
8.4.2. Government & Academic Research Centers
Chapter 9. Global Liquid Biopsy Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Liquid Biopsy Market, Regional Market Snapshot
9.4. North America Liquid Biopsy Market
9.4.1. U.S. Liquid Biopsy Market
9.4.1.1. Product and Services breakdown estimates & forecasts, 2020-2030
9.4.1.2. Circulating Biomarker breakdown estimates & forecasts, 2020-2030
9.4.1.3. Cancer Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-user breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Liquid Biopsy Market
9.5. Europe Liquid Biopsy Market Snapshot
9.5.1. U.K. Liquid Biopsy Market
9.5.2. Germany Liquid Biopsy Market
9.5.3. France Liquid Biopsy Market
9.5.4. Spain Liquid Biopsy Market
9.5.5. Italy Liquid Biopsy Market
9.5.6. Rest of Europe Liquid Biopsy Market
9.6. Asia-Pacific Liquid Biopsy Market Snapshot
9.6.1. China Liquid Biopsy Market
9.6.2. India Liquid Biopsy Market
9.6.3. Japan Liquid Biopsy Market
9.6.4. Australia Liquid Biopsy Market
9.6.5. South Korea Liquid Biopsy Market
9.6.6. Rest of Asia Pacific Liquid Biopsy Market
9.7. Latin America Liquid Biopsy Market Snapshot
9.7.1. Brazil Liquid Biopsy Market
9.7.2. Mexico Liquid Biopsy Market
9.8. Middle East & Africa Liquid Biopsy Market
9.8.1. Saudi Arabia Liquid Biopsy Market
9.8.2. South Africa Liquid Biopsy Market
9.8.3. Rest of Middle East & Africa Liquid Biopsy Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Guardant Health
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Grail
10.3.3. Illumina , Inc
10.3.4. Freenome
10.3.5. Biocept , Inc
10.3.6. Natera , Inc.
10.3.7. Cardiff OncologyTrovagene
10.3.8. RainDance Technologies
10.3.9. Adaptive Biotechnologies
10.3.10. Exosome Diagnostics , Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now